Synergy Pharmaceuticals, Inc.
Records under this name other than patents Synergy Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Synergy Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,041,786 | Guanylate Cyclase Receptor Agonists for the Treatment of Tissue Inflammation and Carcinogenesis now held by Bausch Health Ireland Limited In force · High confidence | In force | High confidence | |
| US 8,901,075 | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders now held by Bausch Health Ireland Limited In force · Medium confidence | In force | Medium confidence | |
| US 9,238,677 | Agonists of Guanylate Cyclase Useful For the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders now held by Bausch Health Ireland Limited In force · High confidence | In force | High confidence | |
| US 9,266,926 | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders now held by Bausch Health Ireland Limited In force · High confidence | In force | High confidence | |
| US 9,914,752 | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders now held by Bausch Health Ireland Limited In force · Medium confidence | In force | Medium confidence | |
| US 9,089,612 | Method of Inhibiting Bile Acid Absorption by Administering An Agonist of a Guanylate Cyclase Receptor now held by Bausch Health Ireland Limited In force · Medium confidence | In force | Medium confidence | |
| US 7,879,802 | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders now held by Bausch Health Ireland Limited In force · High confidence | In force | High confidence | |
| US 8,207,295 | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders now held by Bausch Health Ireland Limited In force · High confidence | In force | High confidence | |
| US 8,357,775 | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders now held by Bausch Health Ireland Limited In force · High confidence | In force | High confidence | |
| US 8,497,348 | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders now held by Bausch Health Ireland Limited In force · High confidence | In force | High confidence |